Abstract: Diphenylalkanoether and diphenylalkanone oxime-ether derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are each independently an aryl group optionally substituted with 1 to 3 substituents selected from the group consisting of halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro, cyano, di(C.sub.1 -C.sub.4)alkylamino, amino, benzyloxy, hydroxyl, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulfinyl, C.sub.1 -C.sub.4 alkylsulfonyl, C.sub.1 -C.sub.4 alkanoylamino, C.sub.1 -C.sub.4 alkylamino and N-(C.sub.1 -C.sub.4)alkyl-N-(C.sub.1 -C.sub.4)alkanoylamino, Z.sup.1 is a group of the formula: ##STR2## (wherein R.sup.3 and R.sup.4 are each independently a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group or an ar(C.sub.1 -C.sub.

Abstract: .alpha.-Bromoacetophenone-oxime-ethers are prepared by reacting acetophenone-oxime-ethers with a brominating agent at from 20.degree. to 100.degree. C., in the absence of light.The .alpha.-bromoacetophenone-oxime-ethers obtained are valuable starting materials for the preparation of drugs, dyes and pesticides.

Abstract: Disclosed are compounds such as 5-(2-chloro-4-trifluoromethylphenoxy)-2-nitroacetophenone oxime-O-methyl ether, and the method of controlling weeds, such as wild oats with the compounds.

Abstract: Compounds of the formula: ##STR1## wherein R and R.sup.1 are alkyl C.sub.1 -C.sub.4 are useful as color formers for pressure- and heat-sensitive copying materials.

Abstract: Derivatives of p-chloroacetophenone oxime, the preparation thereof and the use thereof as medicaments.The compounds of the invention correspond to the general formula I ##STR1## wherein R.sub.1 and R.sub.2 each represent a lower alkyl radical, preferably a C.sub.1 to C.sub.4 radical, or, in association with the nitrogen atom to which they are linked, form a saturated heterocyclic group, and the physiologically acceptable acid addition salts.The compounds of the invention are useful as medicaments and particularly as analgesics, antipyretics, anti-inflammatory agents and antitussives.

Abstract: A compound effective in the treatment of diabetic angiopathy, i.e. a selective .beta.-receptor blocker has the formula ##STR1## wherein: R.sup.2 is a hydrogen or alkyl having one to five carbon atoms,R.sup.3 is alkyl having one to five carbon atoms, cycloalkyl or phenyl optionally substituted with hydroxyl or phenyl, or R.sup.2 and R.sup.3 together form a five- to eight-membered ring optionally containing also other heteroatoms and/or fused with another ring, preferably phenyl, naphthyl, quinolyl, isoquinolyl, pyridyl, pyrazolyl,R.sup.5 is hydrogen or alkyl having one to four carbon atoms, cycloalkyl or phenyl optionally substituted with halogen, alkoxy having one to four carbon atoms or alkyl having one to four carbons,R.sup.6 is hydrogen, alkyl having one to four carbon atoms or phenyl, m=0, 1 or 2, and n=0, 1 or 2.

Abstract: In the preparation of an .omega.-azolyl-acetophenone oxime ether of the formula ##STR1## in which R is halogen, alkyl, alkoxy, alkylthio, alkylsulphonyl, halogenoalkyl, nitro, cyano, optionally substituted phenyl or optionally substituted phenoxy,R' is alkyl, alkenyl, alkynyl, optionally substituted cycloalkylalkyl, optionally substituted aralkyl or optionally substituted aralkenyl,n is 1, 2 or 3,Hal is halogen, andZ is CH or N,wherein the .omega.-halogen of an .omega.-halogeno-acetophenone of the formula ##STR2## is replaced by an azole of the formula ##STR3## and the keto oxygen is replaced by.dbd.N--O--R.sup.1,the improvement which comprises first reacting the .omega.-halogeno-acetophenone with a hydroxylamine ether of the formulaH.sub.2 N--O--R'to produce an .omega.-halogeno-acetophenone oxime ether of the formula ##STR4## and reacting the acetophenone oxime ether with the azole, thereby to obtain the desired product in enhanced yield. The intermediate acetophenone oxime ethers are new.

Abstract: This invention relates to imidazole and triazole compounds useful as fungicides, herbicides and plant growth regulators; to a process for preparing them; to compositions containing them; and to methods of using them to combat fungal infections in plants and to control the growth of vegetation.

Abstract: The invention relates to novel cyclododecane derivatives of the general formula ##STR1## wherein R.sup.1 and R.sup.2 represent independently from each other a hydrogen atom, a C.sub.1-6 alkyl group or a C.sub.3-8 cycloalkyl group, or R.sup.1 and R.sup.2 form together with the nitrogen atom to which they are attached a heterocyclic ring containing 4 to 7 carbon atoms and optionally a further heteroatom selected from the group consisting of oxygen, sulphur and nitrogen, said ring may be optionally substituted by a C.sub.1-3 alkyl or benzyl group; and A represents a C.sub.2-6 straight or branched alkylene chain, and optically active isomers, acid addition salts and quaternary ammonium derivatives thereof. The invention relates further to an analogous process for the preparation of said compounds, to pharmaceutical compositions containing said compounds as the active ingredient and to a process for the preparation of said pharmaceutical compositions.

Abstract: A method of combating Botrytis fungi, comprising applying to such fungi, or to a habitat thereof to be protected against such fungus a fungicidally effective amount of a 1-(2,4-dichlorophenyl)-1-(2,6-dihalogenobenzyloximino)-2-(1,2,4-triazol-1- yl)-ethane of the formula ##STR1## in which X and Y each independently is halogen or a physiologically acceptable acid addition salt thereof. Those compounds in which X is chlorine or fluorine and Y is fluorine are new.

Abstract: Novel 4-monoalkylamino-benzaldehydes, 4-mono-alkylamino-alkanophenones, and 4-monoalkylamino-benzophenones, and derivatives and salts thereof, are disclosed which are useful as anti-atherosclerotic agents.

Abstract: The invention concerns 6-methoxy-2-acetylnaphthalene oxime derivatives of the general formula ##STR1## in which R.sub.1 and R.sub.2 each represent a lower alkyl radical, or form, in association with the nitrogen atom to which they are linked, a saturated heterocyclic group, and the acid addition salts thereof with physiologically acceptable acids. These derivatives have analgesic, antipyretic and anti-inflammatory activity and can be made up into pharmaceutical compositions in tablet, capsule, suppository and the like forms. The derivatives of the invention may be prepared by reacting the corresponding 2-acetyl-6-methoxynaphthalene oximes with an appropriate substituted halogeno-ethylamine.

Abstract: Disclosed are compounds such as 5-(2-chloro-4-trifluoromethylphenoxy)-2-nitroacetophenone oxime-O-methyl ether, and the method of controlling weeds, such as wild oats with the compounds.

Abstract: Insecticidal benzyl oxime ethers of the formula: ##STR1## wherein the symbols have meanings defined in the specification.